Navigation Links
American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter
Date:2/7/2008

(5,188)

Cash and Cash Equivalents, Beginning

of Period 21,426 6,872

Cash and Cash Equivalents, End of

Period $38,160 $1,684

AMERICAN PACIFIC CORPORATION

Supplemental Data

(Unaudited, Dollars in Thousands)

Three Months Ended

December 31,

2007 2006

Operating Segment Data:

Revenues:

Specialty Chemicals $15,549 $11,790

Fine Chemicals 26,762 17,591

Aerospace Equipment 3,735 3,976

Other Businesses 844 1,531

Total Revenues $46,890 $34,888

Segment Operating Income (Loss):

Specialty Chemicals $5,879 $3,493

Fine Chemicals 4,661 2,919

Aerospace Equipment 173 186

Other Businesses (18) 593

Total Segment Operating Income 10,695 7,191

Corporate Expenses (3,471) (2,796)

Operating Income $7,224 $4,395

Depreciation and Amortization:

Specialty Chemicals $1,258 1,282

Fine Chemicals 3,372 3,697

Aerospace Equipment 57 32

Other Businesses 3 3<
'/>"/>

SOURCE American Pacific Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Data From Antheras Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions
2. American Red Cross Responds to Tornadoes in the Southeast
3. Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
4. Massive American Red Cross Tornado Relief Effort Spans Five States
5. Sodium Content Foods and Beverages Gain Revenues as Americans are Embracing Low- and No-Sodium Campaigns
6. Vitals.com Goes Red for American Heart Month
7. American Heart Month: Cracking Open Heart Health Myths
8. Consumer Reports Poll: Americans Demand Health Reform But Are Unsure About How to Achieve it
9. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
10. Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
11. Shareholder Class Action Filed Against American Dental Partners, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Too Much Sun, Too Few Antioxidants Spell Eye Trouble 2Health News:Too Much Sun, Too Few Antioxidants Spell Eye Trouble 3Health News:American Council on Exercise (ACE) Studies Impact of Boot Camp-Style Workouts 2Health News:Randy Jackson and the American Heart Association Encourage New York City Residents to 'Get in the K.N.O.W.' About Improving Type 2 Diabetes Management 2Health News:FairWarning(R) Announces New Privacy Surveillance Software Release 2Health News:FairWarning(R) Announces New Privacy Surveillance Software Release 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4
Breaking Medicine Technology:TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 2Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 3Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 4Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 5Nplate(R) Data From MDS Studies Presented at ASH 2Nplate(R) Data From MDS Studies Presented at ASH 3Nplate(R) Data From MDS Studies Presented at ASH 4Nplate(R) Data From MDS Studies Presented at ASH 5Nplate(R) Data From MDS Studies Presented at ASH 6Nplate(R) Data From MDS Studies Presented at ASH 7Nplate(R) Data From MDS Studies Presented at ASH 8Nplate(R) Data From MDS Studies Presented at ASH 9Nplate(R) Data From MDS Studies Presented at ASH 10Florida Gentle Dental Dentists Giving Away Smile Makeover and Orthodontic Braces at 7th Annual Our Kids World Family Fun Festival 54944 1Florida Gentle Dental Dentists Giving Away Smile Makeover and Orthodontic Braces at 7th Annual Our Kids World Family Fun Festival 54944 2Florida Gentle Dental Dentists Giving Away Smile Makeover and Orthodontic Braces at 7th Annual Our Kids World Family Fun Festival 54944 3Mantaro Partners with Sparsense to Deliver High Performance Digital Image and Signal Processing Solutions 54940 1Mantaro Partners with Sparsense to Deliver High Performance Digital Image and Signal Processing Solutions 54940 2Mantaro Partners with Sparsense to Deliver High Performance Digital Image and Signal Processing Solutions 54940 3Increased climate volatility expected to worsen poverty vulnerability in developing countries 9633 1Increased climate volatility expected to worsen poverty vulnerability in developing countries 9633 2